Log in to save to my catalogue

ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole

ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2236173230

ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole

About this item

Full title

ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-06, Vol.14 (6), p.e0217495-e0217495

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Chronic inflammation is a typical characteristic of polycystic ovary syndrome (PCOS), in which, tumor necrosis factor (TNF)-α plays an important role. We investigated whether anti-TNF-α therapy can alleviate the core phenotypes of PCOS. In pubertal female Wistar rats, release pellets of letrozole (LET) were administered continuously for 90 days to...

Alternative Titles

Full title

ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2236173230

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2236173230

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0217495

How to access this item